Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen's Denosumab Delay Not a Deal-Breaker; Cancer Remains the Big Question
Amgen's Denosumab Delay Not a Deal-Breaker; Cancer Remains the Big Question
Amgen's Denosumab Delay Not a Deal-Breaker; Cancer Remains the Big Question
Submitted by
admin
on October 20, 2009 - 10:34am
Source:
BNET Pharma
News Tags:
Amgen
Prolia
FDA
osteoporosis
denosumab
Headline:
Amgen's Denosumab Delay Not a Deal-Breaker; Cancer Remains the Big Question
Do Not Allow Advertisers to Use My Personal information
